Stockreport

Jasper Therapeutics GAAP EPS of -$0.32 beats by $0.48 [Seeking Alpha]

Jasper Therapeutics, Inc. - Class A  (JSPR) 
PDF More on Jasper Therapeutics Jasper Therapeutics, Inc. (JSPR) Discusses Updated Data from BEACON and Open-Label Extension Studies in Chronic Urticaria - Slideshow Ja [Read more]